Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 2581-2586, June 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Izzard, R. A.
Right arrow Articles by Smith, G. C. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Izzard, R. A.
Right arrow Articles by Smith, G. C. M.
[Cancer Research 59, 2581-2586, June 1, 1999]
© 1999 American Association for Cancer Research


Biochemistry

Competitive and Noncompetitive Inhibition of the DNA-dependent Protein Kinase1

Rebecca A. Izzard, Stephen P. Jackson2 and Graeme C. M. Smith

Wellcome/CRC Institute, Cambridge, CB2 1QR; and Department of Zoology, University of Cambridge, Cambridge, CB2 3EJ, United Kingdom

The DNA-dependent protein kinase (DNA-PK) is a serine/threonine protein kinase that is involved in mammalian DNA double-strand break repair. The catalytic subunit of DNA-PK (DNA-PKcs) shares sequence homology in its kinase domain with phosphatidylinositol (PI) 3-kinase. Here, we provide a detailed kinetic analysis of DNA-PK inhibition by the PI 3-kinase inhibitor wortmannin and demonstrate this inhibition to be of a noncompetitive nature, with a Ki of 120 nM. Another inhibitor of PI 3-kinase, LY294002, its parent compound, quercetin, and other derivatives have also been studied. These chemicals are competitive inhibitors of DNA-PK, with LY294002 having a Ki of 6.0 µM. Using an antibody to wortmannin, we found that this compound binds covalently to the kinase domain of DNA-PKcs both in vitro and in vivo. Binding of wortmannin to the active site of DNA-PKcs is inhibited by ATP but not by a peptide substrate. Furthermore, wortmannin is able to bind to DNA-PKcs independently of Ku, and it is not stimulated by the presence of DNA. This suggests that the ATP binding site of DNA-PKcs is open constitutively and that DNA activation of the kinase is mediated via another mechanism.




This article has been cited by other articles:


Home page
Cancer Res.Home page
R. Prevo, E. Deutsch, O. Sampson, J. Diplexcito, K. Cengel, J. Harper, P. O'Neill, W. G. McKenna, S. Patel, and E. J. Bernhard
Class I PI3 Kinase Inhibition by the Pyridinylfuranopyrimidine Inhibitor PI-103 Enhances Tumor Radiosensitivity
Cancer Res., July 15, 2008; 68(14): 5915 - 5923.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
E. Willmore, S. L. Elliott, T. Mainou-Fowler, G. P. Summerfield, G. H. Jackson, F. O'Neill, C. Lowe, A. Carter, R. Harris, A. R. Pettitt, et al.
DNA-Dependent Protein Kinase Is a Therapeutic Target and an Indicator of Poor Prognosis in B-Cell Chronic Lymphocytic Leukemia
Clin. Cancer Res., June 15, 2008; 14(12): 3984 - 3992.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. D. Kao, Z. Jiang, A. M. Fernandes, A. K. Gupta, and A. Maity
Inhibition of Phosphatidylinositol-3-OH Kinase/Akt Signaling Impairs DNA Repair in Glioblastoma Cells following Ionizing Radiation
J. Biol. Chem., July 20, 2007; 282(29): 21206 - 21212.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Z. Jiang, N. Pore, G. J. Cerniglia, R. Mick, M.-M. Georgescu, E. J. Bernhard, S. M. Hahn, A. K. Gupta, and A. Maity
Phosphatase and Tensin Homologue Deficiency in Glioblastoma Confers Resistance to Radiation and Temozolomide that Is Reversed by the Protease Inhibitor Nelfinavir
Cancer Res., May 1, 2007; 67(9): 4467 - 4473.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
L. Geng, X. Zhang, S. Zheng, and R. J. Legerski
Artemis Links ATM to G2/M Checkpoint Recovery via Regulation of Cdk1-Cyclin B
Mol. Cell. Biol., April 1, 2007; 27(7): 2625 - 2635.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. M. Al-Alwan, K. Okkenhaug, B. Vanhaesebroeck, J. S. Hayflick, and A. J. Marshall
Requirement for Phosphoinositide 3-Kinase p110{delta} Signaling in B Cell Antigen Receptor-Mediated Antigen Presentation
J. Immunol., February 15, 2007; 178(4): 2328 - 2335.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
L. de la Pena, W. E. Burgan, D. J. Carter, M. G. Hollingshead, M. Satyamitra, K. Camphausen, and P. J. Tofilon
Inhibition of Akt by the alkylphospholipid perifosine does not enhance the radiosensitivity of human glioma cells.
Mol. Cancer Ther., June 1, 2006; 5(6): 1504 - 1510.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. Zhao, H. D. Thomas, M. A. Batey, I. G. Cowell, C. J. Richardson, R. J. Griffin, A. H. Calvert, D. R. Newell, G. C.M. Smith, and N. J. Curtin
Preclinical Evaluation of a Potent Novel DNA-Dependent Protein Kinase Inhibitor NU7441.
Cancer Res., May 15, 2006; 66(10): 5354 - 5362.
[Abstract] [Full Text] [PDF]


Home page
GENES CELLSHome page
R. Sakasai, K. Shinohe, Y. Ichijima, N. Okita, A. Shibata, K. Asahina, and H. Teraoka
Differential involvement of phosphatidylinositol 3-kinase-related protein kinases in hyperphosphorylation of replication protein A2 in response to replication-mediated DNA double-strand breaks
Genes Cells, March 1, 2006; 11(3): 237 - 246.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Frasca, E. Van der Put, A. M. Landin, D. Gong, R. L. Riley, and B. B. Blomberg
RNA Stability of the E2A-Encoded Transcription Factor E47 Is Lower in Splenic Activated B Cells from Aged Mice
J. Immunol., November 15, 2005; 175(10): 6633 - 6644.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
R. Parsons
Phosphatidylinositol 3-Kinase Inhibitors Are a Triple Threat to Ovarian Cancer
Clin. Cancer Res., November 15, 2005; 11(22): 7965 - 7966.
[Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. Yaneva, H. Li, T. Marple, and P. Hasty
Non-homologous end joining, but not homologous recombination, enables survival for cells exposed to a histone deacetylase inhibitor
Nucleic Acids Res., September 21, 2005; 33(16): 5320 - 5330.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. E. Santiago-Walker, A. J. Fikaris, G. D. Kao, E. J. Brown, M. G. Kazanietz, and J. L. Meinkoth
Protein Kinase C {delta} Stimulates Apoptosis by Initiating G1 Phase Cell Cycle Progression and S Phase Arrest
J. Biol. Chem., September 16, 2005; 280(37): 32107 - 32114.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. W. Poh and S. Pervaiz
LY294002 and LY303511 Sensitize Tumor Cells to Drug-Induced Apoptosis via Intracellular Hydrogen Peroxide Production Independent of the Phosphoinositide 3-Kinase-Akt Pathway
Cancer Res., July 15, 2005; 65(14): 6264 - 6274.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
L. Erker, R. Schubert, H. Yakushiji, C. Barlow, D. Larson, J. B. Mitchell, and A. Wynshaw-Boris
Cancer chemoprevention by the antioxidant tempol acts partially via the p53 tumor suppressor
Hum. Mol. Genet., June 15, 2005; 14(12): 1699 - 1708.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. Deriano, O. Guipaud, H. Merle-Beral, J.-L. Binet, M. Ricoul, G. Potocki-Veronese, V. Favaudon, Z. Maciorowski, C. Muller, B. Salles, et al.
Human chronic lymphocytic leukemia B cells can escape DNA damage-induced apoptosis through the nonhomologous end-joining DNA repair pathway
Blood, June 15, 2005; 105(12): 4776 - 4783.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. L. Bladen, D. Udayakumar, Y. Takeda, and W. S. Dynan
Identification of the Polypyrimidine Tract Binding Protein-associated Splicing Factor{middle dot}p54(nrb) Complex as a Candidate DNA Double-strand Break Rejoining Factor
J. Biol. Chem., February 18, 2005; 280(7): 5205 - 5210.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. Kysela, M. Chovanec, and P. A. Jeggo
Phosphorylation of linker histones by DNA-dependent protein kinase is required for DNA ligase IV-dependent ligation in the presence of histone H1
PNAS, February 8, 2005; 102(6): 1877 - 1882.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
I. Hickson, Y. Zhao, C. J. Richardson, S. J. Green, N. M. B. Martin, A. I. Orr, P. M. Reaper, S. P. Jackson, N. J. Curtin, and G. C. M. Smith
Identification and Characterization of a Novel and Specific Inhibitor of the Ataxia-Telangiectasia Mutated Kinase ATM
Cancer Res., December 15, 2004; 64(24): 9152 - 9159.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
X. Zhang, J. Succi, Z. Feng, S. Prithivirajsingh, M. D. Story, and R. J. Legerski
Artemis Is a Phosphorylation Target of ATM and ATR and Is Involved in the G2/M DNA Damage Checkpoint Response
Mol. Cell. Biol., October 15, 2004; 24(20): 9207 - 9220.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
W. D. Block, Y. Yu, D. Merkle, J. L. Gifford, Q. Ding, K. Meek, and S. P. Lees-Miller
Autophosphorylation-dependent remodeling of the DNA-dependent protein kinase catalytic subunit regulates ligation of DNA ends
Nucleic Acids Res., August 16, 2004; 32(14): 4351 - 4357.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Biol.Home page
D. A. Solomon, M. C. Cardoso, and E. S. Knudsen
Dynamic targeting of the replication machinery to sites of DNA damage
J. Cell Biol., August 16, 2004; 166(4): 455 - 463.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
E. Willmore, S. de Caux, N. J. Sunter, M. J. Tilby, G. H. Jackson, C. A. Austin, and B. W. Durkacz
A novel DNA-dependent protein kinase inhibitor, NU7026, potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemia
Blood, June 15, 2004; 103(12): 4659 - 4665.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Tanno, N. Yanagawa, A. Habiro, K. Koizumi, Y. Nakano, M. Osanai, Y. Mizukami, T. Okumura, J. R. Testa, and Y. Kohgo
Serine/Threonine Kinase AKT Is Frequently Activated in Human Bile Duct Cancer and Is Associated with Increased Radioresistance
Cancer Res., May 15, 2004; 64(10): 3486 - 3490.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
W. D. Block, D. Merkle, K. Meek, and S. P. Lees-Miller
Selective inhibition of the DNA-dependent protein kinase (DNA-PK) by the radiosensitizing agent caffeine
Nucleic Acids Res., April 1, 2004; 32(6): 1967 - 1972.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Stiff, M. O'Driscoll, N. Rief, K. Iwabuchi, M. Lobrich, and P. A. Jeggo
ATM and DNA-PK Function Redundantly to Phosphorylate H2AX after Exposure to Ionizing Radiation
Cancer Res., April 1, 2004; 64(7): 2390 - 2396.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
A. Kashishian, H. Douangpanya, D. Clark, S. T. Schlachter, C. T. Eary, J. G. Schiro, H. Huang, L. E. Burgess, E. A. Kesicki, and J. Halbrook
DNA-dependent protein kinase inhibitors as drug candidates for the treatment of cancer
Mol. Cancer Ther., December 1, 2003; 2(12): 1257 - 1264.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. Li, Y. Takeda, S. Wragg, J. Barrett, A. Phillips, and W. S. Dynan
Modification of the ionizing radiation response in living cells by an scFv against the DNA-dependent protein kinase
Nucleic Acids Res., October 15, 2003; 31(20): 5848 - 5857.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
S. Durant and P. Karran
Vanillins--a novel family of DNA-PK inhibitors
Nucleic Acids Res., October 1, 2003; 31(19): 5501 - 5512.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. J. Veuger, N. J. Curtin, C. J. Richardson, G. C. M. Smith, and B. W. Durkacz
Radiosensitization and DNA Repair Inhibition by the Combined Use of Novel Inhibitors of DNA-dependent Protein Kinase and Poly(ADP-Ribose) Polymerase-1
Cancer Res., September 15, 2003; 63(18): 6008 - 6015.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Sak, M. Stuschke, R. Wurm, G. Schroeder, B. Sinn, G. Wolf, and V. Budach
Selective Inactivation of DNA-dependent Protein Kinase with Antisense Oligodeoxynucleotides: Consequences for the Rejoining of Radiation-induced DNA Double-Strand Breaks and Radiosensitivity of Human Cancer Cell Lines
Cancer Res., November 15, 2002; 62(22): 6621 - 6624.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
G. W. Krystal, G. Sulanke, and J. Litz
Inhibition of Phosphatidylinositol 3-Kinase-Akt Signaling Blocks Growth, Promotes Apoptosis, and Enhances Sensitivity of Small Cell Lung Cancer Cells to Chemotherapy
Mol. Cancer Ther., September 1, 2002; 1(11): 913 - 922.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. Edwards, L. Geng, J. Tan, H. Onishko, E. Donnelly, and D. E. Hallahan
Phosphatidylinositol 3-Kinase/Akt Signaling in the Response of Vascular Endothelium to Ionizing Radiation
Cancer Res., August 15, 2002; 62(16): 4671 - 4677.
[Abstract] [Full Text] [PDF]


Home page
Learn. Mem.Home page
P. K. Dash, S. A. Mach, S. Blum, and A. N. Moore
Intrahippocampal Wortmannin Infusion Enhances Long-Term Spatial and Contextual Memories
Learn. Mem., July 1, 2002; 9(4): 167 - 177.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Karmakar, J. Piotrowski, R. M. Brosh Jr., J. A. Sommers, S. P. L. Miller, W.-H. Cheng, C. M. Snowden, D. A. Ramsden, and V. A. Bohr
Werner Protein Is a Target of DNA-dependent Protein Kinase in Vivo and in Vitro, and Its Catalytic Activities Are Regulated by Phosphorylation
J. Biol. Chem., May 17, 2002; 277(21): 18291 - 18302.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Blancher, J. W. Moore, N. Robertson, and A. L. Harris
Effects of ras and von Hippel-Lindau (VHL) Gene Mutations on Hypoxia-inducible Factor (HIF)-1{alpha}, HIF-2{alpha}, and Vascular Endothelial Growth Factor Expression and Their Regulation by the Phosphatidylinositol 3'-Kinase/Akt Signaling Pathway
Cancer Res., October 1, 2001; 61(19): 7349 - 7355.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Tezuka, H. Watanabe, S. Nakamura, D. Yu, W. Aung, T. Sasaki, H. Shibuya, and M. Miura
Antiapoptotic Activity Is Dispensable for Insulin-like Growth Factor I Receptor-mediated Clonogenic Radioresistance after {gamma}-Irradiation
Clin. Cancer Res., October 1, 2001; 7(10): 3206 - 3214.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
H. Pospiech, A. K. Rytkonen, and J. E. Syvaoja
The role of DNA polymerase activity in human non-homologous end joining
Nucleic Acids Res., August 1, 2001; 29(15): 3277 - 3288.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. K. Gupta, V. J. Bakanauskas, G. J. Cerniglia, Y. Cheng, E. J. Bernhard, R. J. Muschel, and W. G. McKenna
The Ras Radiation Resistance Pathway
Cancer Res., May 1, 2001; 61(10): 4278 - 4282.
[Abstract] [Full Text]


Home page
J. Virol.Home page
I. Han, S. Harada, D. Weaver, Y. Xue, W. Lane, S. Orstavik, B. Skalhegg, and E. Kieff
EBNA-LP Associates with Cellular Proteins Including DNA-PK and HA95
J. Virol., March 1, 2001; 75(5): 2475 - 2481.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Kultz and D. Chakravarty
Hyperosmolality in the form of elevated NaCl but not urea causes DNA damage in murine kidney cells
PNAS, February 13, 2001; 98(4): 1999 - 2004.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. Danilkovitch, S. Donley, A. Skeel, and E. J. Leonard
Two Independent Signaling Pathways Mediate the Antiapoptotic Action of Macrophage-Stimulating Protein on Epithelial Cells
Mol. Cell. Biol., March 15, 2000; 20(6): 2218 - 2227.
[Abstract] [Full Text]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. C. M. Smith, R. B. Cary, N. D. Lakin, B. C. Hann, S.-H. Teo, D. J. Chen, and S. P. Jackson
Purification and DNA binding properties of the ataxia-telangiectasia gene product ATM
PNAS, September 28, 1999; 96(20): 11134 - 11139.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. Frit, R.-Y. Li, D. Arzel, B. Salles, and P. Calsou
Ku Entry into DNA Inhibits Inward DNA Transactions in Vitro
J. Biol. Chem., November 10, 2000; 275(46): 35684 - 35691.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D.-P. Li, S. Periyasamy, T. J. Jones, and E. R. Sanchez
Heat and Chemical Shock Potentiation of Glucocorticoid Receptor Transactivation Requires Heat Shock Factor (HSF) Activity. MODULATION OF HSF BY VANADATE AND WORTMANNIN
J. Biol. Chem., August 18, 2000; 275(34): 26058 - 26065.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. E. Geddis, N. E. Fox, and K. Kaushansky
Phosphatidylinositol 3-Kinase Is Necessary but Not Sufficient for Thrombopoietin-induced Proliferation in Engineered Mpl-bearing Cell Lines as Well as in Primary Megakaryocytic Progenitors
J. Biol. Chem., September 7, 2001; 276(37): 34473 - 34479.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.